ACHL — Achilles Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Achilles Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	97.6	178	266	173	132
Net Total Receivables	0.327	1.13	0.65	0.771	0.793
Prepaid Expenses
Total Other Current Assets
Total Current Assets	103	188	285	197	146
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.11	28.1	28.8	20.5	13.5
Other Long Term Assets
Total Assets	105	219	317	220	161
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.86	16.6	19.1	18	17
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.86	29.5	27.6	23.3	19.1
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	101	189	290	197	142
Total Liabilities & Shareholders' Equity	105	219	317	220	161
Total Common Shares Outstanding